← 홈

Antibody

1,830개 · ADC 1068 · Antibody 5456 · CGT 2744 · 다음 갱신 D-12 · 마지막 7월 13일

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 1,830개
AntibodystaleMeletios A. DimopoulosPhase 2

Bortezomib, Rituximab, Dexamethasone (Bortezomib, Rituximab, Dexamethasone)

Waldenstrom's Macroglobulinemia · Waldenstrom's Macroglobulinemia

#WaldenstromsMacroglobulinemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleJanssenPhase 3

daratumumab (Darzalex, VTD, Bortezomib, Thalidomide, Dexamethasone, Bortezomib, Thalidomide, Dexamethasone (VTD) + daratumumab)

Multiple Myeloma · Multiple Myeloma

#MultipleMyeloma#Antibody#Phase3#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleProvidence Health & ServicesPhase 2

Bortezomib, Thymoglobulin, Rituximab, Gamimune N, (IVIG, Bortezomib, Thymoglobulin, Rituximab, Gamimune N,, Bortezomib, Thymoglobulin, Rituximab, Gamimune N, (IVIG), Plasmapheresis)

Heart Transplantation · Heart Transplantation

#HeartTransplantation#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleFondazione Italiana Linfomi - E…Phase 2

Bortezomib-Rituximab-Bendamustine (Bortezomib-Rituximab-Bendamustine)

Waldenstrom's Macroglobulinemia · Waldenstrom's Macroglobulinemia

#WaldenstromsMacroglobulinemia#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleMerckPhase 1

pembrolizumab (Keytruda, Bortezomib; pembrolizumab and cisplatin injections--bortezomib followed by pembro/cis)

Breast Cancer · Breast Cancer

#BreastCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 RECRUITING
AntibodystaleAstraZenecaPhase 3

Brazikumab high dose (Brazikumab high dose)

Crohn's Disease; IBD · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleAstraZenecaPhase 3

Brazikumab low dose (Brazikumab low dose)

Crohn's Disease; IBD · Crohn's Disease

#CrohnsDisease#Antibody#Phase3#항체#면역항체+3
임상시험 1상태 DISCONTINUED
AntibodystaleEli LillyPhase 1

Brivanib + Cetuximab (Brivanib + Cetuximab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleRadboud University Medical Cent…Approved

Brodalumab (Brodalumab)

Psoriasis; Psoriasis Vulgaris · Psoriasis

#Psoriasis#Antibody#Approved#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleSun Yat-sen UniversityPhase 2

cetuximab (C225, C225 (cetuximab))

Nasopharyngeal Carcinoma · Nasopharyngeal Carcinoma

#NasopharyngealCarcinoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleNational Cancer Center, KoreaPhase 2

nivolumab (Opdivo, CA and Nivolumab)

Non-small Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleGenzyme, a Sanofi CompanyPhase 2

alemtuzumab (CAMPATH, CAMPATH (alemtuzumab))

Non-Hodgkin's Lymphoma · Non-Hodgkin's Lymphoma

#Non-HodgkinsLymphoma#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNational Cancer Centre, Singapo…Phase 2

pembrolizumab (Keytruda, CAPEOX/Pembrolizumab)

Colorectal Cancer · Colorectal Cancer

#ColorectalCancer#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleChinese PLA General HospitalPhase 2

CAPOX combined with bevacizumab and Tislelizumab (CAPOX combined with bevacizumab and Tislelizumab)

Advanced Gastroesophageal Adenocarcinoma; First-line Therapy · Advanced Gastroesophageal Adenocarcinoma

#AdvancedGastroesophagealAdenocar#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 ACTIVE
AntibodystaleRochePhase 2

CAPOX+ Camrelizumab+ Bevacizumab (CAPOX+ Camrelizumab+ Bevacizumab)

Unresectable Metastatic Rectal Cancer; CAPOX · Unresectable Metastatic Rectal Cancer

#UnresectableMetastaticRectalCanc#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleEli LillyPhase 2

CAPOX+ Camrelizumab+ Cetuximab (CAPOX+ Camrelizumab+ Cetuximab)

Unresectable Metastatic Rectal Cancer; CAPOX · Unresectable Metastatic Rectal Cancer

#UnresectableMetastaticRectalCanc#Antibody#Phase2#항체#면역항체+3
임상시험 1상태 RECRUITING
AntibodystaleGerman Cancer Research CenterPhase 2

CC-1 and Toczilizumab (CC-1 and Toczilizumab)

Lung Cancer Squamous Cell · Lung Cancer Squamous Cell

#LungCancerSquamousCell#Antibody#Phase2#항체#면역항체+2
임상시험 1상태 DISCONTINUED
AntibodystaleNantes University HospitalPreclinical

CEEP-RITUXIMAB (CEEP-RITUXIMAB)

Lymphoma, Large-Cell, Diffuse · Lymphoma, Large-Cell, Diffuse

#LymphomaLarge-CellDiffuse#Antibody#Preclinical#항체#면역항체+5
임상시험 1상태 ACTIVE
AntibodystaleProgen PharmaceuticalsPhase 1

CGC-11047 and bevacizumab (CGC-11047 and bevacizumab)

Cancer · Cancer

#Cancer#Antibody#Phase1#항체#면역항체+2
임상시험 1상태 ACTIVE
AntibodystaleWeill Medical College of Cornel…Phase 1

CHOP and alemtuzumab (CHOP and alemtuzumab)

T-Cell Lymphoma; Lymphoma, Non-Hodgkin's · T-Cell Lymphoma

#T-CellLymphoma#Antibody#Phase1#항체#면역항체+4
임상시험 1상태 ACTIVE

31 / 92 페이지

← 이전다음 →